[Disturbances in fetal homeostasis and neonatal resuscitation. II. Evaluation of the clinical conditions of the infant at birth and treatment of neonatal function disturbances].
D000142:Acidosis, Respiratory / Q000628:therapy*; D001238:Asphyxia Neonatorum / Q000188:drug therapy*; D001549:Benzamides / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001833:Body Temperature Regulation; D002396:Catechols / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D036861:Delivery, Obstetric; D005260:Female; D005315:Fetal Diseases / Q000628:therapy*; D006706:Homeostasis; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007977:Levallorphan / Q000627:therapeutic use; D009269:Nalorphine / Q000627:therapeutic use; D010101:Oxygen Consumption; D011247:Pregnancy; D012119:Respiration; D012131:Respiratory Insufficiency / Q000628:therapy*; D012151:Resuscitation; D014325:Tromethamine / Q000627:therapeutic use
D001549:Benzamides; D001565:Benzoates; D002396:Catechols; D000697:Central Nervous System Stimulants; D014325:Tromethamine; D007977:Levallorphan; D009269:Nalorphine
Disturbi nell'omeostasi fetale e rianimazione neonatale. II. Valutazione delle condizioni cliniche del bambino alla nascita e trattamento dei disturbi della funzionalità neonatale.